The Blood Connection Incorporated is a 501(c)(3) organization based in Piedmont, South Carolina, registered in 1978, with $144,446,573 in FY2023 revenue. CharityIndex grades it A+, and it directs about 94% of spending to programs.
Revenue (FY2023)
$144.4M
▲ 22.1% vs prior year
Health median: $840K
Expenses (FY2023)
$138.4M
Net assets
$64.8M
Employees
1,558
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For The Blood Connection Incorporated: 94% to programs · $0 to raise $100 earns a A+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For The Blood Connection Incorporated: 6 mo reserves · +4% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For The Blood Connection Incorporated: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For The Blood Connection Incorporated: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Provide community blood banking & transfusion medicine and cellular transplantation services.
See schedule o blood processing storage and distribution: provision of blood components to healthcare providers: on a fee for service basis, preparation and distribution of blood components to hospitals, clinics, dialysis centers, blood banks, and blood fractionators. goal: prepare blood components and distribute according to needs of healthcare clients. maintain consistent (5-7 day supply) inventory of all types units of plasma distributed for blood derivative preparation. cost containment for healthcare of blood components, for healthcare clients, number of patient beneficiaries, derived health benefits, lives saved.
See schedule o laboratory and cellular services: donated blood testing program: uses laboratory serologic, chemistry, and infectious disease assays to assess the suitability of donated blood, platelets and plasma. for donors detection of infectious disease for which donor may seek treatment. positive public health consequences of disease detection, partner notification, exposure control.
Hematopoietic progenitor cell processing services: provides cellular therapy services including processing, cryopreservation, storage, infusion preparations for immunotherapy, and transplant for both autologous and matched related transplants for multiple myeloma, nhl and hodgkinis lymphoma. provides transplant product preparation and shipment preparation to an outside facility upon request. the cryogenic storage services are provided free of charge for the first year. goals: process 100% of requests for processing and infusions of hematopoietic progenitor cells and donor lymphocytes, offer services 24/7, provide same day turnaround for cd34+ flow cytometry analysis, and produce a product proven to be capable of engraftment. cellular therapy collection services: provides cellular collection services for two healthcare providers. one, a biotechnology company (dendreon) applies its expertise in antigen identification, engineering and cell processing to produce an active cellular immunotherapy product called provenge (sipuleucel-t). provenge is indicated for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. the blood connection collects mononuclear cells from prostate cancer patients deemed suitable by their physician and scheduled by dendreon. post collection, the collected product is shipped to dendreon for further testing and processing; the final product is later transfused back to the patient at their transfusion center. the other provider is a cancer treatment institute affiliated with a local hospital system. the blood connection collects circulating bone marrow cells from patients in the remission phase of cellular cancers such as leukemia, lymphoma, and myeloma. those collections, rich in hematopoietic progenitor cells, are then processed as described above. additional program expenses include interest expenses and program related administrative expenses.
Revenue grew from $34.6M (FY2013) to $144.4M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
4.2%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$101.9M
Total liabilities
$37.2M
Net assets
$64.8M
Salaries & benefits
$53.8M
39% of expenses
Board members
12
12 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $144,446,573▲22.1% | $138,430,065▲21.3% | $64,774,139▲11.6% | $101,949,398▲14.1% | 990 |
| 2022 | $118,297,630▲20.7% | $114,124,812▲22.0% | $58,024,116▲9.4% | $89,385,846▲23.4% | 990 |
| 2021 | $98,048,523▼1.3% | $93,545,312▲6.2% | $53,023,460▲7.6% | $72,423,076▲3.3% | 990 |
| 2020 | $99,339,992▲38.0% | $88,042,897▲24.3% | $49,255,826▲34.7% | $70,119,104▲14.0% | 990 |
| 2019 | $71,973,109▲18.7% | $70,841,417▲19.8% | $36,560,693▲2.5% | $61,532,414▲18.5% | 990 |
| 2018 | $60,638,522▲24.0% | $59,130,277▲25.3% | $35,661,021▲2.2% | $51,912,327▲14.5% | 990 |
| 2017 | $48,893,393▲8.5% | $47,188,214▲9.6% | $34,907,684▲5.7% | $45,332,023▲5.8% | 990 |
| 2016 | $45,056,735▲21.4% | $43,074,303▲21.1% | $33,018,741▲7.9% | $42,863,857▲8.6% | 990 |
| 2015 | $37,105,178▲7.6% | $35,570,348▲2.8% | $30,596,630▲4.9% | $39,483,426▲5.4% | 990 |
| 2014 | $34,479,340▼0.5% | $34,611,079▲4.0% | $29,155,154▼3.3% | $37,449,424▼1.7% | 990 |
| 2013 | $34,637,062 | $33,268,630▼3.2% | $30,138,464▲4.8% | $38,081,176▲1.4% | 990 |
| 2012 | — | $34,365,956▲7.6% | $28,754,616▲0.9% | $37,569,975▲2.2% | 990 |
| 2011 | — | $31,931,864▲17.1% | $28,508,539▲6.6% | $36,777,645▲5.6% | 990 |
| 2010 | — | $27,270,692▲12.7% | $26,735,571▲6.1% | $34,839,261▲5.2% | 990 |
| 2009 | — | $24,198,062 | $25,202,616 | $33,108,506 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Delisa English — $471,899 (0.34% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Delisa English | President/ceo | 40 | $471,899 |
| Brian Madden | Executive Vp/coo | 40 | $364,267 |
| Tracy Bridges | Executive Vp/chief Technical Officer | 40 | $293,140 |
| Don Hall | Cfo | 40 | $269,561 |
| Denise Calloway | Vp/chief Quality Officer | 40 | $246,694 |
| William Mimbs | Vp of Operational Support | 40 | $201,241 |
| Latronya Rodgers | Vp of Clinical Support | 40 | $191,577 |
| Ryan Horejsi | Sr Director of Hr | 40 | $174,942 |
| Troy Kidd | Divisional Director III | 40 | $169,892 |
| Amber Fuller | Sr Director of Technical Services | 40 | $147,505 |
| Theresa Botti | Divisional Director II | 40 | $146,775 |
| Mario Sedlock | Regional Director | 40 | $144,590 |
| Amanda Farrell | Senior Director of Donor Resources | 40 | $122,609 |
| Stephanie Ezell | Director of Donor Resources | 40 | $121,825 |
| Ben Abzug | Trustee | 2 | — |
| Brent Odom | Trustee | 2 | — |
| Chad Richards | Trustee | 2 | — |
| Forrest Long | Trustee | 2 | — |
| Heidi Phillips | Trustee | 2 | — |
| Jessica Mccoy | Trustee | 2 | — |
| Contractor | Services | Paid |
|---|---|---|
| It Synergistics LLC | Software Services | $761,077 |
| Baker Motor Company of Summerville LLC | Auto Dealership | $459,878 |
| Cnp Technologies | Technology Support Services | $329,231 |
| Eagle Express of Sc LLC | Courier Service | $315,889 |
| Health Aware LLC | Marketing | $212,324 |
Explore more
Data for The Blood Connection Incorporated (EIN 57-0660489) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.